Plasma Concentrations of Cholecystokinin and Neurotensin in Patients with Cystic Fibrosis

K. H. Herzig Depts. of Internal Medicine and Surgery, Georg-August-University, Göttingen; Dept. of Pediatrics, University of Göttingen, Göttingen; Dept. of Internal Medicine, Christian-Albrechts-University, Kiel; Dept. of Pediatrics, University of Hamburg, Hamburg, Germany; Dept. of Pediatrics, University of Poznań, Poznań, Poland

J. Domagk Depts. of Internal Medicine and Surgery, Georg-August-University, Göttingen; Dept. of Pediatrics, University of Göttingen, Göttingen; Dept. of Internal Medicine, Christian-Albrechts-University, Kiel; Dept. of Pediatrics, University of Hamburg, Hamburg, Germany; Dept. of Pediatrics, University of Poznań, Poznań, Poland

R. Nustede Depts. of Internal Medicine and Surgery, Georg-August-University, Göttingen; Dept. of Pediatrics, University of Göttingen, Göttingen; Dept. of Internal Medicine, Christian-Albrechts-University, Kiel; Dept. of Pediatrics, University of Hamburg, Hamburg, Germany; Dept. of Pediatrics, University of Poznań, Poznań, Poland

M. Stern Depts. of Internal Medicine and Surgery, Georg-August-University, Göttingen; Dept. of Pediatrics, University of Göttingen, Göttingen; Dept. of Internal Medicine, Christian-Albrechts-University, Kiel; Dept. of Pediatrics, University of Hamburg, Hamburg, Germany; Dept. of Pediatrics, University of Poznań, Poznań, Poland

B. Bewig Depts. of Internal Medicine and Surgery, Georg-August-University, Göttingen; Dept. of Pediatrics, University of Göttingen, Göttingen; Dept. of Internal Medicine, Christian-Albrechts-University, Kiel; Dept. of Pediatrics, University of Hamburg, Hamburg, Germany; Dept. of Pediatrics, University of Poznań, Poznań, Poland

W. K. Cichy Depts. of Internal Medicine and Surgery, Georg-August-University, Göttingen; Dept. of Pediatrics, University of Göttingen, Göttingen; Dept. of Internal Medicine, Christian-Albrechts-University, Kiel; Dept. of Pediatrics, University of Hamburg, Hamburg, Germany; Dept. of Pediatrics, University of Poznań, Poznań, Poland

U. R. Fölsch Depts. of Internal Medicine and Surgery, Georg-August-University, Göttingen; Dept. of Pediatrics, University of Göttingen, Göttingen; Dept. of Internal Medicine, Christian-Albrechts-University, Kiel; Dept. of Pediatrics, University of Hamburg, Hamburg, Germany; Dept. of Pediatrics, University of Poznań, Poznań, Poland

show all

Abstract

Background: Regulation of pancreatic exocrine secretion is controlled by vagovagal reflexes and hormones. A negative feedback control mechanism exists between the intraduodenal protease concentration and pancreatic enzyme secretion. In man cholecystokinin (CCK) is the major regulator of postprandial pancreatic enzyme secretion. There is a 50% reduction of meal-stimulated secretion by the specific CCK receptor antagonist loxiglumide, whereas atropine completely blocks postprandial secretion. Neurotensin is released postprandially by nerval reflexes and fat. It has been claimed that both hormones are increased in patients with pancreatic insufficiency. Methods: We investigated CCK and neurotensin levels in patients with cystic fibrosis and pancreatic insufficiency. In 35 patients (2–24 years old) with cystic fibrosis with steatorrhea and in 15 patients (1.5–24 years old) with cystic fibrosis without pancreatic insufficiency pre-and post-prandial CCK and neurotensin plasma levels were measured 3 days after pancreatic enzyme therapy had been withdrawn. Nine patients (3–14 years old) who had no complaint of abdominal disease served as controls. Results: Basal and postprandial CCK plasma levels did not differ statistically in the three groups, whereas basal and postprandial neurotensin levels were significantly increased in the cystic fibrosis groups. The severity of the disease had no effect on the neurotensin levels. Conclusions: Cystic fibrosis patients with severe pancreatic insufficiency did not have increased CCK plasma levels, suggesting that a CCK-mediated feedback mechanism of pancreatic enzyme secretion does not operate in our patients. In contrast, basal and postprandial neurotensin plasma levels were significantly increased in patients with cystic fibrosis but were independent of the severity of the pancreatic insufficiency.

Key Words:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Plasma Concentrations of Cholecystokinin and Neurotensin in Patients with Cystic Fibrosis

Information for

Open access

Opportunities

Help and information

Plasma Concentrations of Cholecystokinin and Neurotensin in Patients with Cystic Fibrosis

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature